HUTCHMED(HCM)

Search documents
HUTCHMED(HCM) - 2021 Q4 - Annual Report
2022-03-02 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark one) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 co ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR Date of event requiring this shell comp ...
HUTCHMED(HCM) - 2021 Q2 - Earnings Call Transcript
2021-07-28 19:00
HUTCHMED (China) Limited (NASDAQ:HCM) Q2 2021 Earnings Conference Call July 28, 2021 8:00 AM ET Company Participants Christian Hogg - Chief Executive Officer Mark Lee - Senior Vice President Corporate Finance & Development Wei-Guo Su - Chief Scientific Officer Marek Kania - Managing Director for HUTCHMED International & Chief Medical Officer Conference Call Participants Alec Stranahan - Bank of America Louise Chen - Cantor David Ng - Macquarie Paul Choi - Goldman Sachs Mike Mitchell - Panmure Gordon Operato ...
HUTCHMED(HCM) - 2020 Q4 - Earnings Call Transcript
2021-03-04 20:03
Hutchison China MediTech Limited (NASDAQ:HCM) Q4 2020 Earnings Conference Call March 4, 2021 8:00 AM ET Company Participants Christian Hogg - CEO Wei-guo Su - CSO & Head, R&D Marek Kania - CMO Johnny Cheng - CFO Conference Call Participants Louise Chen - Cantor Ethan Ding - Morgan Stanley Alec Stranahan - Bank of America Paul Choi - Goldman Sachs John Newman - Canaccord Genuity Tony Ren - CLSA Rajan Sharma - Deutsche Bank Christian Hogg Okay. Thank you. This is Christian Hogg, CEO of HUTCHMED. And today we ...